Followers | 31 |
Posts | 1581 |
Boards Moderated | 0 |
Alias Born | 10/18/2019 |
Sunday, September 04, 2022 10:37:34 AM
Nvcr has gone from $20 to now $80 with a peak a bit over $220 so reasonably similar.
Now the 7 and 8 year charts - my time frame in both and the story is vastly different. At the time I greatly enjoyed the nwbo ride to $12.54 and listening to the ceo really thought nwbo was on the way to greatness. Outstanding shares well under 100 million, direct phase 1 looked very promising, dcvax-L results per the ceo to be out in 18 months all imo looked great. I did not really enjoy the ride down to 14 cents though I did buy more.
Nvcr in that time was teens to high single digits, it went on an upward ride to over $220 but (my bad - obviously) I sold nvcr at 20 and $25 to purchase more nwbo and though I made $ I sure missed the big payoff. I really did not like the discomfort for patients wearing the hat.
I really quit following nvcr much but have now done some dd and generally some favorable results
Nwbo from may 10th presentation we know also has favorable results at near 3 months added at the median and 13% five year survival. Imo we also know it is not the miracle cure often talked about here with 30% and up five year survival - one was thinking 50% 'cure' for methylated and one post claimed 80% response rate.
Toms and Ashkan say speak favorably of both so I believe both have merit
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM